Admission Date:  [**2128-5-28**]              Discharge Date:   [**2128-6-3**]  Date of Birth:  [**2079-12-10**]             Sex:   F  Service: MEDICINE  Allergies: Zoloft  Attending:[**First Name3 (LF) 11597**] Chief Complaint: SOB  Major Surgical or Invasive Procedure: During this hospitaliztion, you required an tube in your airway to assist in breathing.
History of Present Illness: 48 yoF with h/o dilated CMP (EF25-30%), asthma, initially admitted [**2128-5-29**] with asthma exacerbation.
She also noted a cough productive of yellow sputum for 2-3 days without fever, chest pain, LE edema, PND, or othopnea.
CXR was without focal infiltrate.
However, on the night of [**2128-5-30**], she developed progressively worsening shortness of breath, not responsive to nebs.
Repeat CXR was without evidence of infiltrate or CHF and ABG 7.11/104/108 on 100% FM.
Past Medical History: 1) Idiopathic dilated CMP, followed by CHF service 2) Depression 3) Thyroid cancer 4) Type II DM 5) Iron deficiency anemia related to vaginal bleeding 6) Barretts esophagus 7) Asthma 8) Sickle cell trait   Social History: No tobacco or IVDU, rare EtOH.
HEENT: PERRL, EOMI, anicteric, nl conjunctiva, OMMM, OP clear, neck supple, JVP ~ 10 cm Cardiac: Distant heart sounds, regular, no M/R/G Pulm: Diffuse wheezes with decreased air movement throughout.
Abd: NABS, soft, mild epigastric tenderness without rebound or guarding.
No HSM Ext: No cynosis or edema Neuro: Moves all 4 extremities equally, 2+ DTR throughout   Pertinent Results: No lab results available for import.
Asthma exacerbation/Respiratory failure: As detailed in HPI.
Initially admitted with simple asthma exacerbation, treated with nebs and steroids.
However, on the night of [**2128-5-30**], she developed progressively worsening shortness of breath, not responsive to nebs.
Repeat CXR was without evidence of infiltrate or CHF and ABG 7.11/104/108 on 100% FM.
She was discharged on albuterol and atrovent MDIs, as well as with home nebs for prn use, and with a prednisone taper.
Questionable contribution to asthma exacerbation and respiratory failure during this admission, though with a normal pro-BNP prior to MICU transfer and a normal CXRs as an inpatient.
Carvedilol dose as outpatient was maximum dose, decreased secondary to bradycardia to 6.25 mg [**Hospital1 **].
DM type II: Maintained on insulin SS as inpatient, clincially stable during hospitalization.
Respiratory failure 2. asthma exacerbation 2.
Discharge Instructions: To patient:  Please return to the emergency department for acute shortness of breath uncontrolled by your outpatient medications, problems breathing at night, or swelling in your extremities.
You should also return to the ED for general changes in your health including fever (>101F), chills, of dizziness.
If you feel dizzy or lightheaded, you should stop taking this medication.
